FAQ: Predictive Oncology's $344.4 Million Digital Asset Treasury Strategy with ATH Token
Summary
Predictive Oncology Inc. has priced $344.4 million in private placements to fund a new digital asset treasury strategy focused on accumulating ATH tokens from the Aethir ecosystem. This significant capital raise supports the company's expansion into digital assets while maintaining its core focus on AI-driven cancer drug discovery.
What is the main announcement from Predictive Oncology?
Predictive Oncology announced the pricing of two concurrent private placement transactions totaling approximately $344.4 million to support its new digital asset treasury strategy centered on ATH, the native token of the Aethir ecosystem.
How is the $344.4 million funding structured?
The funding consists of a $51.7 million cash PIPE and a $292.7 million crypto PIPE involving pre-funded warrants, with proceeds earmarked for ATH acquisition, working capital, and general corporate purposes.
What is Predictive Oncology’s core business focus?
Predictive Oncology specializes in using artificial intelligence and machine learning to expedite early drug discovery and enable drug development for cancer patients worldwide, featuring their scientifically validated AI platform called PEDAL.
What is the PEDAL platform and what does it do?
PEDAL is Predictive Oncology’s scientifically validated AI platform that can predict with 92% accuracy if a tumor sample will respond to a certain drug compound, allowing for more informed selection of drug/tumor type combinations for subsequent testing.
What resources does Predictive Oncology have for drug discovery?
The company maintains a vast biobank of more than 150,000 assay-capable heterogenous human tumor samples and operates a wholly owned CLIA laboratory facility, providing one of the industry’s broadest AI-based drug discovery solutions.
Where is Predictive Oncology headquartered?
Predictive Oncology is headquartered in Pittsburgh, PA.
Where can I find more information about Predictive Oncology?
For more information, visit the company’s website at https://predictive-oncology.com/
Where can I view the full press release?
To view the full press release, visit https://ccw.fm/oIn6g
What is ATH in relation to this announcement?
ATH is the native utility token of the Aethir ecosystem that Predictive Oncology will focus on accumulating as part of its new digital asset treasury strategy.
This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)
Article Control ID: 239228